due
product
condit
today
newborn
farm
anim
cattl
pig
hors
goat
sheep
exhibit
failur
passiv
transfer
fpt
direct
consequ
increas
suscept
diseas
first
week
life
necessit
wide
use
antibiot
consequ
increas
antibioticresist
diarrheal
strain
bacteria
becom
fact
altern
use
antibiot
oral
applic
immunoglobulin
product
period
greatest
risk
ie
within
first
day
life
postwean
period
airdri
egg
yolk
immunoglobulin
igi
cow
colostrum
swine
serum
produc
larg
scale
provid
greatest
chanc
mass
applic
work
present
import
principl
prophylact
therapeut
oral
applic
immunoglobulin
basi
publish
literatur
author
investig
surfac
mucos
membran
exce
hundr
time
skin
mucos
membran
gastrointestin
tract
massiv
contact
extern
environ
occur
colon
host
tissu
bacteria
begin
bind
bacteri
surfac
adhesin
appropri
ligand
host
cell
soto
hultgren
stage
involv
break
host
defens
prolifer
damag
host
tissu
kaper
et
al
effect
protect
potenti
infect
via
rout
consider
challeng
organ
digest
tract
protect
system
consist
natur
barrier
epitheli
continu
mucu
secret
peristalt
motil
low
ph
gastric
juic
etc
nonspecif
humor
immun
factor
complement
lysozym
defensin
etc
nonspecif
cellular
immun
factor
macrophag
granulocyt
dendrit
cell
specif
humor
immun
antibodi
specif
cellular
immun
factor
b
lymphocyt
effici
immun
system
healthi
anim
depend
cooper
mechan
mention
mueller
et
al
sheldrak
husband
riedelcaspari
schmidt
honoriofranca
et
al
statist
concern
occurr
gastrointestin
tract
patholog
young
anim
indic
age
group
often
prone
failur
organ
protect
system
day
birth
specif
immun
cell
found
neonat
digest
tract
colon
mucos
membran
lymphat
structur
lymphocyt
take
place
gradual
first
immun
cell
intestin
identifi
week
life
navarro
et
al
aminova
et
al
concentr
compar
adult
anim
achiev
month
life
effect
selfact
specif
humor
cellular
immun
regard
insuffici
import
role
play
selfsecretori
iga
main
mucos
immunoglobulin
ig
protect
level
achiev
week
life
mestecki
et
al
macpherson
et
al
howev
nonspecif
immun
mechan
effici
although
activ
may
slightli
lower
adult
anim
mueller
et
al
observ
mention
indic
maintain
gastrointestin
tract
homeostasi
first
week
life
depend
larg
extent
passiv
protect
matern
immun
stefaniak
earli
drink
colostrum
provid
supplement
antibodi
gastrointestin
tract
mellor
murray
due
protect
provid
matern
antibodi
microorgan
enter
neonat
digest
tract
korhonen
et
al
palmeira
et
al
limit
success
attack
mucos
membran
colostr
compon
immunomodul
andor
antimicrobi
substanc
includ
lactoferrin
lysozym
lactoperoxidas
cytokin
wagstrom
et
al
et
al
blum
baumruck
solomon
also
consider
signific
protect
newborn
furthermor
colostr
compon
also
contribut
cellular
immun
eg
signific
number
matern
cell
may
contribut
neonat
immun
includ
phagocyt
neutrophil
macrophag
lymphocyt
b
cell
epitheli
cell
wagstrom
et
al
interest
natur
protect
colostr
mechan
provid
presenc
solubl
receptor
analog
block
microbi
adhesin
pathogen
factor
lindahl
kelli
younson
exampl
bind
fimbria
enterotoxigen
strain
escherichia
coli
glycoprotein
present
cow
sow
colostrum
due
pathogen
adher
intestin
epithelium
neonat
becom
weaken
lindahl
howev
import
protect
role
play
specif
antibodi
antigen
present
neonat
environ
riedelcaspari
korhonen
et
al
le
rousic
et
al
crouch
et
al
pisarska
et
al
matern
antibodi
obtain
colostrum
milk
protect
neonat
infect
effici
specif
immun
protect
develop
fig
cow
produc
least
l
first
colostrum
contain
least
ig
gl
equal
g
per
calf
kruse
tyler
et
al
studi
kruse
cow
give
l
colostrum
show
igg
concentr
gl
similar
data
obtain
levieux
ollier
point
fact
calv
origin
primipar
cow
endang
insuffici
passiv
protect
immunoglobulin
concentr
secret
rumin
mammari
gland
decreas
rapidli
parturit
instanc
cow
milk
remain
gl
milk
gl
milk
levieux
ollier
fig
protect
gut
specif
antibodi
pathogen
factor
attack
unprotect
mucos
membran
b
protect
due
earli
feed
immun
colostrum
andor
prophylact
oral
immunoglobulin
supplement
high
concentr
antibodi
protect
mucos
membran
igg
antibodi
colostrum
oral
immunoglobulin
supplement
siga
antibodi
origin
colostrum
produc
local
low
quantiti
within
gut
young
anim
specif
receptor
bacteri
adhesin
toxin
virus
etc
pathogen
factor
bacteri
viral
toxic
specif
antibodi
inadequaci
toward
environment
microb
facilit
earli
colon
neonat
digest
tract
well
suscept
diseas
fig
believ
main
role
cellular
compon
mammari
secret
interact
develop
local
immun
newborn
modul
activ
immun
neonat
intestin
critic
period
especi
import
develop
young
le
jan
barrington
parish
today
product
practic
newborn
larg
farm
anim
cattl
swine
hors
goat
sheep
develop
failur
passiv
transfer
fpt
halawa
stefaniak
fpt
mean
acquir
humor
specif
immun
defici
neonat
due
insuffici
absorpt
matern
colostr
immunoglobulin
fig
direct
consequ
increas
suscept
diseas
first
week
life
calv
exhibit
inadequ
igg
concentr
greater
risk
neonat
morbid
prewean
mortal
mcguir
et
al
vermunt
wittum
perino
rea
et
al
tyler
et
al
necessit
wide
use
antibiot
increas
antibioticresist
bacteri
strain
common
use
antibiot
protect
young
anim
diarrhea
becom
less
less
effect
accompani
rais
consum
awar
safe
food
antibioticfre
revis
definit
safe
food
new
understand
point
food
deriv
anim
kept
welfar
condit
without
antibiot
treatment
throughout
life
anoth
reason
withdraw
antibiot
search
altern
kelli
younson
mine
kovacsnolan
lack
selfantibodi
bind
microbi
adhesin
host
receptor
molecul
critic
earli
step
microbi
infect
pathogenesi
bacteri
toxin
also
requir
first
stage
bind
specif
ligand
girardeau
bertin
exemplari
wellrecogn
adhesin
bacteri
enterotoxin
appropri
ligand
present
tabl
therefor
possibl
block
interact
seem
attract
mean
prevent
infect
earli
stage
oral
applic
antiadhesin
antibodi
commonli
use
strategi
adhesionblock
altern
aid
investig
especi
adhesin
analogu
receptor
analogu
kelli
younson
oral
administ
specif
antibodi
enteropathogen
virus
block
develop
diarrhea
result
infect
rotaand
coronavirus
besser
et
al
snodgrass
et
al
heckert
et
al
erhard
et
al
ikemori
et
al
two
main
period
highest
risk
diarrhea
frank
kaneen
vermunt
sivula
et
al
yokoyama
et
al
requir
local
immun
supplement
neonat
period
age
day
main
risk
factor
enterotoxigen
e
coli
rotaviru
infect
postwean
period
associ
stress
chang
feed
programm
highest
risk
first
week
new
environ
therefor
research
wide
applic
immunoglobulin
prophylaxi
anim
gastrointestin
tract
diseas
ensu
ascertain
method
health
protect
appli
far
base
massiv
antibiot
administr
effici
enough
caus
numer
side
effect
contrast
high
effici
prophylact
therapeut
oral
applic
antibodi
indic
fig
one
method
treatment
acquir
immun
defici
young
anim
oral
applic
immunoglobulin
prepar
contain
antibodi
direct
incrimin
digest
tract
pathogen
bogst
et
al
barrington
et
al
import
sourc
antibodi
use
protect
alimentari
tract
newborn
farm
anim
airdri
cow
colostrum
egg
yolk
immunoglobulin
swine
serum
hain
et
al
facon
et
al
lerous
et
al
shibata
et
al
derouchey
et
al
owusuasiedu
et
al
b
stefaniak
et
al
choic
antibodi
sourc
purif
method
need
made
consider
circumst
use
target
anim
specif
cost
quantiti
need
tabl
b
allogen
antibodi
cooper
hostspecif
immun
mechan
main
posit
effect
rapid
elimin
pathogen
agent
hand
induc
unintend
tissu
injuri
due
complement
activ
mucos
membran
bystand
effect
bovin
colostrum
purifi
igg
absorb
calf
neonat
intestin
effect
nativ
colostr
immunoglobulin
airdri
colostr
immunoglobulin
swine
serum
immunoglobulin
given
similar
concentr
arthington
et
al
b
absorb
allogen
immunoglobulin
induc
immun
respons
due
intraspeci
antigen
similar
passiv
acquir
colostr
igg
antibovin
rotaviru
diffus
blood
gut
mucos
membran
day
calf
life
besser
et
al
case
intens
infect
antibodi
insuffici
protect
gastrointestin
tract
diarrhea
howev
oral
supplement
calv
bovin
colostr
immunoglobulin
concentr
result
higher
serum
immunoglobulin
concentr
within
first
week
life
addit
improv
weight
gain
diminish
incid
diarrhea
nousiainen
et
al
kind
antibodi
could
well
merit
common
usag
protect
young
anim
import
inform
applic
xenogen
antibodi
administ
period
ig
absorpt
gut
bloodstream
eg
foal
hour
life
calv
hour
piglet
lamb
goat
kid
hour
xenogen
protein
appear
blood
recipi
anim
stimul
immun
respons
foreign
epitop
present
given
immunoglobulin
consequ
lead
fast
ig
elimin
remov
immun
complex
week
ingest
although
absorpt
effect
allogen
ig
stefaniak
ga
sowska
stefaniak
contrast
absorpt
occur
risk
observ
older
anim
usual
hour
life
lack
occurr
less
intens
interact
cooper
immun
mechan
may
advantag
protect
healthi
gastrointestin
tract
bind
specif
antibodi
pathogen
fig
prevent
interact
microb
mucos
membran
follow
immun
exclus
remov
fece
practic
airdri
egg
yolk
immunoglobulin
cow
colostrum
swine
serum
method
allow
largescal
product
low
cost
heat
treatment
reduc
microbiolog
contamin
final
product
allow
longterm
storag
howev
import
disadvantag
air
dri
loss
antibodi
activ
reach
stefaniak
greatest
denatur
aggreg
cow
immunoglobulin
influenc
temperatur
occur
ph
close
isoelectr
point
et
al
dominguez
et
al
sensit
immunoglobulin
heat
tendenc
aggreg
increas
low
concentr
salt
solut
although
heat
treatment
airdri
pasteur
uht
caus
consider
decreas
activ
specif
antibodi
korhonen
et
al
stefaniak
still
maintain
restrict
activ
month
storag
lyophil
antibodi
preserv
activ
year
storag
stefaniak
stefaniak
stefaniak
et
al
although
also
oral
appli
young
anim
rel
high
cost
low
effici
freezedri
result
abandon
method
egg
yolk
antibodi
vaccin
lay
hen
seem
cheaper
good
sourc
antibodi
jin
et
al
simultan
addit
spraydri
porcin
plasma
egg
yolk
antibodi
fodder
earlywean
piglet
appear
interest
idea
owusuasiedu
et
al
main
immunoglobulin
class
mention
antibodi
sourc
igg
comparison
igg
cattl
swine
hen
present
tabl
cow
colostrum
kind
colostrum
use
larg
scale
due
larg
volum
secret
even
overproduct
klobasa
et
al
cow
milk
colostrum
assumpt
sourc
bovin
immunoglobulin
colostrum
swine
porker
blood
serum
hen
egg
lay
hen
cow
kg
bodi
weight
suppli
annual
l
first
colostrum
featur
ig
concentr
gl
porker
gain
bodi
weight
kg
within
half
year
blood
collect
slaughter
suppli
l
blood
serumplasma
concentr
g
igl
lay
hen
attract
sourc
antibodi
willingli
appli
easi
process
bovin
igg
prevail
colostrum
milk
appli
oral
advantag
resist
digest
class
de
rham
islik
resist
subclass
digest
compar
iga
bovin
colostr
secretori
iga
would
also
resist
proteolysi
within
digest
tract
amount
produc
low
mcclead
gregori
presenc
trypsin
inhibitor
colostrum
provid
igg
protect
inhibitor
protect
igg
proteolyt
degrad
intestin
moreov
concentr
posit
correl
igg
concentr
quigley
et
al
oral
given
colostr
antibodi
deriv
cow
immun
rotaviru
clostridium
difficil
retain
activ
passag
human
intestin
roo
et
al
kelli
et
al
pacyna
et
al
longterm
vitro
digest
colostrum
whey
chymotrypsin
result
mainten
antibacteri
igg
activ
simultan
declin
igm
activ
brock
et
al
digest
trypsin
reduc
igg
activ
left
igm
activ
hardli
chang
author
determin
specif
activ
requir
complet
immunoglobulin
molecul
digest
tract
activ
fab
fragment
alon
quit
suffici
satisfactorili
restrict
possibl
contact
organ
mucou
membran
reilli
et
al
protect
mucos
membran
maintain
spite
proteolysi
igg
iga
immunoglobulin
molecul
mcclead
gregori
hilpert
et
al
molla
et
al
wellknown
method
prevent
diarrhea
neonat
calv
twice
day
administr
surplu
colostrum
first
second
milk
mix
milk
milk
substitut
throughout
period
greatest
risk
diarrhea
usual
day
life
castrucci
et
al
gutzwil
cow
colostrum
nonimmun
cow
cow
hyperimmun
rotaviru
coronaviru
escherichia
coli
shigella
success
prevent
diarrhea
also
neonat
speci
brunser
et
al
klobasa
et
al
tzipori
et
al
gomez
et
al
ashraf
et
al
shibata
et
al
sever
indic
applic
cow
colostrum
foal
lamb
kid
klobasa
et
al
winter
clarkson
perl
et
al
lack
low
qualiti
matern
colostrum
mastiti
twin
multipl
fetus
control
infecti
diseas
transmit
colostrum
caprin
arthritisenceph
maedivisna
mycoplasmosi
igi
differ
mammal
igg
higher
molecular
weight
ie
kda
due
occurr
four
c
h
domain
heavi
chain
shimizu
et
al
nakai
et
al
egg
yolk
immunoglobulin
display
high
suscept
aggreg
salt
solut
nacl
suscept
decreas
ph
well
digest
proteolyt
enzym
trypsin
chymotrypsin
less
heatresist
rabbit
igg
shimizu
et
al
hatta
et
al
b
consider
differ
found
resist
low
ph
proteolysi
heat
igi
cattl
goat
swine
igg
shimizu
et
al
dominguez
et
al
egg
yolk
rich
sourc
igi
contain
mg
igyml
valu
one
calcul
singl
lay
hen
produc
g
igi
per
year
mine
kovacsnolan
proport
anim
bodi
mass
product
volum
immunoglobulin
sever
time
higher
compar
sourc
rabbit
swine
serum
cow
colostrum
noninvas
harvest
egg
easi
igi
isol
addit
advantag
tini
et
al
far
igi
appli
prophylaxi
therapi
calv
enterotox
e
coli
salmonella
spp
rotavirus
coronavirus
cryptosporidium
spp
piglet
enterotox
e
coli
rotavirus
mice
rotavirus
rabbit
enterotox
e
coli
also
human
enterotox
enteropathogen
e
coli
rotaviru
barz
et
al
ofarelli
et
al
yokoyama
et
al
erhard
et
al
ikemori
et
al
amar
et
al
igi
prepar
success
appli
period
greatest
risk
ie
neonat
newli
wean
anim
yet
egg
yolk
immunoglobulin
use
far
larg
scale
human
except
japan
south
korea
addit
yoghurt
sweet
babi
food
singl
dose
mg
igi
hen
immun
e
coli
assur
specif
antibodi
activ
present
h
colon
piglet
age
day
yokoyama
et
al
broiler
chicken
given
g
igykg
feed
igi
antibodi
activ
e
coli
salmonella
enteritidi
typhimurium
klebsiella
pneumonia
record
fece
intens
elisa
reaction
proport
igi
dose
stefaniak
et
al
studi
involv
use
whole
yolk
hen
immun
definit
antigen
experiment
scale
barz
et
al
yokoyama
et
al
rzedzicki
wernicki
erhard
et
al
ikemori
et
al
airdri
immunoglobulin
prepar
obtain
commerci
egg
display
antibodi
activ
diarrheal
strain
escherichia
coli
salmonella
enteritidi
typhimurium
klebsiella
pneumonia
success
appli
dose
gkg
feed
l
milksubstitut
prepar
prophylaxi
diarrhea
wean
calv
well
suckl
wean
piglet
stefaniak
ga
sowska
stefaniak
stefaniak
et
al
high
level
addit
spraydri
whole
egg
restrict
calv
piglet
weight
gain
presenc
proteas
inhibitor
egg
white
well
differ
amino
acid
content
egg
compar
need
mammal
quigley
derouchey
et
al
owusuasiedu
et
al
b
serum
produc
blood
slaughter
swine
allow
largescal
product
immunoglobulin
commonli
use
supplement
fodder
spraydri
porcin
plasma
sdpp
derouchey
et
al
schmidt
et
al
contain
whole
spectrum
serum
protein
includ
biolog
activ
one
commonli
propos
dose
addit
fodder
constitut
import
sourc
alimentari
protein
schmidt
et
al
propos
amount
result
consider
increas
feed
cost
spraydri
swine
plasma
commerci
avail
usa
countri
appli
oral
suckl
earlywean
piglet
due
savouri
fodder
contain
sdpp
piglet
eat
higher
amount
achiev
higher
weight
gain
control
piglet
fed
standard
fodder
rabbit
immun
serum
success
appli
oral
rat
experiment
infect
pathogen
e
coli
strain
rivier
sobotka
immunoglobulin
origin
cow
immun
v
cholera
introduc
satisfactori
result
concern
rabbit
protect
boesmanfinkelstein
et
al
swine
serum
possess
igg
fraction
differ
resist
cleavag
trypsin
pepsin
olsovska
et
al
fact
spraydri
blood
serum
prepar
significantli
contamin
advis
undergo
irradi
derouchey
et
al
import
problem
oral
administr
proteolysi
immunoglobulin
digest
enzym
anoth
problem
caus
inactiv
antibodi
activ
due
low
ph
irrevers
inactiv
nonprotect
igi
occur
ph
method
propos
protect
appli
antibodi
proteolysi
gastric
juic
low
ph
eg
use
hydroxypropyl
methylcellulos
phthalat
ikemori
et
al
opinion
ikemori
cowork
spraydri
igi
hydroxypropyl
methylcellulos
phtalat
result
protect
bind
coat
antibodi
enabl
withstand
acid
condit
retain
antibodi
activ
passag
small
intestin
acid
stabil
igi
enhanc
presenc
sorbitol
lee
et
al
encapsul
igi
liposom
shimizu
et
al
bovin
igg
major
immunoglobulin
cow
colostrum
milk
resist
digest
immunoglobulin
class
regard
advantag
oral
administr
de
rham
islik
high
dose
oral
given
immunoglobulin
resist
digest
low
ph
within
gastrointestin
tract
low
concentr
activ
disappear
reach
posterior
segment
intestin
petschow
talbott
hand
igg
suscept
cleavag
bacteri
proteas
vicin
hing
region
inde
suscept
cleavag
iga
iga
suscept
iga
molla
et
al
oral
given
airdri
immunoglobulin
colostrumsuppl
one
third
effect
absorb
calv
immunoglobulin
fresh
cow
colostrum
garri
et
al
wors
protect
caus
frequent
patholog
calv
rel
low
dose
airdri
igi
gkg
bodi
weight
suppli
newborn
calv
instead
togeth
first
colostrum
absorb
intestin
blood
efficaci
stefaniak
cow
colostrum
given
lamb
goat
kid
intestin
absorpt
immunoglobulin
may
induc
hemolyt
anemia
caus
bind
antibodi
recipi
erythrocyt
winter
clarkson
perl
et
al
cow
colostrum
may
also
sourc
mycobacterium
paratuberculosi
goat
kid
orsel
et
al
product
hyperimmun
anim
mostli
kellner
et
al
alway
effect
come
nonimmun
anim
korhonen
et
al
sarker
et
al
loimaranta
et
al
show
littl
mgml
immun
nonimmun
colostrum
produc
visibl
aggreg
streptococcu
mutan
occur
parallel
reduct
bacteri
adhes
lower
concentr
produc
invis
aggreg
surprisingli
increas
bacteri
adhes
author
believ
cow
colostrum
also
contain
compon
caus
streptococcu
aggreg
immunoglobulin
prepar
nonimmun
anim
eg
airdri
swine
serum
pool
slaughter
contain
antibodi
direct
broad
spectrum
antigen
produc
anim
life
appli
prophylact
may
effect
prevent
adhes
infecti
agent
gut
mucos
membran
protect
gastrointestin
tract
patholog
lissner
et
al
stefaniak
highli
specif
immunoglobulin
prepar
deriv
hyperimmun
anim
show
significantli
higher
effici
regard
homolog
antigen
may
broad
activ
pathogen
pool
larg
number
nonimmun
slaughter
anim
mani
herd
choic
time
durat
oral
applic
antibodi
origin
specif
method
applic
must
made
basi
good
knowledg
farm
question
fig
manag
qualiti
environ
consid
import
pathogen
factor
digest
tract
young
anim
exactli
identifi
essenti
factor
taken
account
econom
assess
highli
purifi
prepar
immun
anim
may
expens
mass
prophylact
applic
ig
addit
feed
milkreplac
tabl
seem
suitabl
prophylaxi
wherea
applic
capsul
administr
ig
concentr
advis
diarrhea
therapi
kelli
et
al
graczyk
et
al
graczyk
et
al
ashraf
et
al
et
al
quigley
et
al
solomon
stefaniak
et
al
stefaniak
et
al
present
fig
number
factor
determin
whether
oral
applic
fulfil
expect
protect
function
mani
factor
depend
peopl
anim
barrington
et
al
stefaniak
stefaniak
et
al
awar
factor
contribut
proper
diagnosi
reduct
risk
diarrhea
given
farm
frank
kaneen
seem
futur
igi
prepar
becom
import
protect
digest
tract
young
mammal
sinc
product
larg
scale
undoubtedli
easier
less
expens
antibodi
schade
hlinak
earlier
investig
carri
team
show
exist
wide
crossreact
frequent
gramneg
bacteria
occur
farm
anim
antibodi
obtain
sever
anim
speci
haemophilu
somnu
crossreact
antigen
e
coli
pasteurella
multocida
p
haemolytica
salmonella
enteritidid
typhimurium
dublin
gallinarumpullorum
klebsiella
pneumonia
stefaniak
et
al
stefaniak
et
al
wieliczko
et
al
crossreact
antigen
mass
kda
stefaniak
et
al
parenter
given
h
somnu
hyperimmun
sera
show
protect
activ
infect
caus
differ
gramneg
bacteria
nikolajczuk
et
al
stefaniak
et
al
seem
extrem
attract
field
practic
isol
antigen
respons
induct
interspeci
protect
product
effect
subunit
vaccin
immun
lay
hen
use
egg
donor
sourc
igi
antibodi
protect
young
anim
find
leastinvas
lowcost
immun
method
well
achiev
hightiterspecif
antibodi
becom
one
import
task
aim
largescal
product
hedlund
hau
decis
concern
igi
dose
herd
high
low
risk
infect
crucial
step
contribut
possibl
lower
cost
protect
young
anim
obtain
highest
clinic
effect
chosen
prepar
futur
igi
expect
use
prevent
epidem
eg
typhu
cholera
environment
disast
treatment
diarrhea
riskgroup
patient
suffer
aid
pregnant
women
protect
newborn
immun
defici
low
birth
weight
et
al
shimizu
et
al
shimizu
et
al
improv
igi
purif
expect
area
technolog
develop
concern
product
prepar
take
account
relat
procedur
cost
protect
effect
prepar
strong
expect
connect
experiment
applic
plantibodi
antibodi
requir
specif
class
produc
transgen
plant
et
al
larrick
et
al
chadd
chamow
peeter
et
al
transgen
plant
may
suitabl
diagnost
therapeut
use
well
largescal
product
recombin
secretori
immunoglobulin
passiv
mucos
immunotherapi
latter
applic
may
prove
revolutionari
field
effici
protect
young
anim
tabl
method
oral
applic
antibodi
mix
fodder
advantag
young
anim
usual
eat
much
wish
voluntari
access
fodder
fodder
contain
ig
tastier
help
better
weight
gain
disadvantag
sick
anim
eat
lack
protect
antibodi
addit
mainli
calv
foal
lamb
goat
kid
colostrum
milkadvantag
conveni
easi
administr
quit
precis
dosag
replac
disadvantag
prepar
usual
appli
twice
day
may
caus
consider
fluctuat
ig
concentr
protect
effect
digest
tract
lumen
capsul
advantag
precis
dosag
protect
low
stomach
ph
disadvantag
addit
servic
necessari
oral
applic
advantag
precis
dosag
concentr
solut
disadvantag
addit
servic
necessari
infect
low
cost
larg
scale
immunoglobulin
product
hiatt
sharp
doran
theoret
obtain
immunoglobulin
transgen
plant
consider
exce
amount
produc
anim
